DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine. (4th November 2015)

• Record Type: Journal Article
• Authors: Anastasopoulou, Eleftheria A; Tzonis, Panagiotis; Fortis, Sotirios P; Mahaira, Louisa; Vaxevanis, Christoforos; Ardavanis, Alexandros; Mittendorf, Elizabeth A; Peoples, George E; Baxevanis, Constantin N; Papamichail, Michael; Perez, Sonia A
• Is Part Of: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
• Publication Date: 2015-11-04
• Subjects: Breast Cancer Patient -- Prostate Cancer Patient -- Peptide Vaccine -- Allele Expression -- Vaccine Group; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1186/2051-1426-3-S2-P427
• Languages: English
• ISSNs: 2051-1426